Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Esophageal Squamous Cell Carcinoma (ESCC)
View Full LandscapeTarget Indication
Esophageal Squamous Cell Carcinoma (ESCC)
Clinical Trial
NCT05342636Last updated: 12/16/2025
No patent data available. Pre-approval drugs may not have Orange Book listings.
Colorectal Adenoma
Acute Hematogenous Osteomyelitis
Dyslipidemia
Type 2 Diabetes Mellitus (T2DM)
Non Small Cell Lung Cancer (NSCLC)